Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02991196
Title Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids Michigan 49503 United States Details
MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
South Texas Accelerated Research Therapeutics, LLC (START) San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field